Milestone Pharmaceuticals, Inc. (MIST)
0.9505
-0.03
(-3.02%)
USD |
NASDAQ |
Sep 14, 16:00
0.9505
0.00 (0.00%)
After-Hours: 16:31
Milestone Pharmaceuticals Price : 0.9505 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 1.06 | 1.081 | 0.98 | 0.9801 | 3.324M |
| Sep 10, 2026 | 1.07 | 1.08 | 1.05 | 1.05 | 1.107M |
| Sep 09, 2026 | 1.13 | 1.14 | 1.07 | 1.07 | 1.315M |
| Sep 08, 2026 | 1.20 | 1.215 | 1.12 | 1.125 | 1.794M |
| Sep 04, 2026 | 1.21 | 1.26 | 1.195 | 1.20 | 1.593M |
| Sep 03, 2026 | 1.22 | 1.26 | 1.195 | 1.21 | 2.029M |
| Sep 02, 2026 | 1.14 | 1.185 | 1.14 | 1.18 | 767736.0 |
| Sep 01, 2026 | 1.14 | 1.155 | 1.115 | 1.14 | 1.020M |
| Aug 31, 2026 | 1.17 | 1.17 | 1.14 | 1.16 | 1.004M |
| Aug 28, 2026 | 1.20 | 1.205 | 1.14 | 1.16 | 865687.0 |
| Aug 27, 2026 | 1.18 | 1.255 | 1.18 | 1.19 | 1.557M |
| Aug 26, 2026 | 1.17 | 1.187 | 1.125 | 1.18 | 727114.0 |
| Aug 25, 2026 | 1.06 | 1.17 | 1.045 | 1.16 | 1.709M |
| Aug 24, 2026 | 1.06 | 1.06 | 1.02 | 1.04 | 1.562M |
| Aug 21, 2026 | 1.07 | 1.07 | 1.03 | 1.055 | 1.917M |
| Aug 20, 2026 | 1.09 | 1.129 | 1.02 | 1.03 | 2.178M |
| Aug 19, 2026 | 1.09 | 1.125 | 1.07 | 1.08 | 2.330M |
| Aug 18, 2026 | 1.07 | 1.11 | 1.050 | 1.07 | 1.481M |
| Aug 17, 2026 | 1.12 | 1.14 | 1.07 | 1.10 | 1.591M |
| Aug 14, 2026 | 1.07 | 1.10 | 1.04 | 1.10 | 2.167M |
| Aug 13, 2026 | 1.09 | 1.12 | 1.06 | 1.07 | 2.669M |
| Aug 12, 2026 | 1.08 | 1.19 | 1.04 | 1.125 | 5.786M |
| Aug 11, 2026 | 1.27 | 1.29 | 1.25 | 1.27 | 1.384M |
| Aug 10, 2026 | 1.23 | 1.29 | 1.20 | 1.26 | 1.627M |
| Aug 07, 2026 | 1.18 | 1.22 | 1.16 | 1.22 | 990172.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.305 |
| NervGen Pharma Corp. | 2.19 |
| Clearmind Medicine, Inc. | 0.92 |
| Lexaria Bioscience Corp. | 3.51 |
| Target Group, Inc. (Canada) | 0.0011 |
Price Related Metrics
| PS Ratio | 47.84 |
| Price to Book Value | 6.496 |
| Earnings Yield | -72.99% |
| Market Cap | 118.34M |